Aim of the webinar:
The webinar speakers will discuss the definitions and frequencies of weak or discrepant RhD phenotypes and the serological and genetic mechanisms for how they arise. The speakers will describe when to perform RHD genotyping in patients to resolve phenotyping problems; how RHD molecular results in these cases vary by race, ethnicity and world regions; and how to apply genotyping to RhD management of obstetrical patients and transfusion recipients.
Level of education required:
2 to 5
(2 - Novice (limited experience), 3 - intermediate (practical application), 4 - Advanced (applied theory), 5 - Expert (recognized authority)
What prior knowledge is required?
The attendees should consider reading the following articles:
- Epidemiology of Hemostatic Transfusions in Children Supported by Extracorporeal Membrane Oxygenation
- Anticoagulation and hemostasis on extracorporeal membrane oxygenation
- Transfusion management for children supported by extracorporeal membrane oxygenation
- Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis
Target audience
Transfusion practitioners, blood bankers, experts in anticoagulation.
The Speakers